Loading...

Xvivo Perfusion AB (publ)

XVIPF•PNK
Healthcare
Medical - Devices
$19.15
$-3.66(-16.05%)
U.S. Market opens in 4h 43m

Xvivo Perfusion AB (publ) (XVIPF) Stock Overview

Explore Xvivo Perfusion AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap603.2M
P/E Ratio219.63
EPS (TTM)$0.09
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$5.76
3 Months$8.52
1 Year Target$30.51

XVIPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Xvivo Perfusion AB (publ) (XVIPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.37, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $30.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 219.63 and a market capitalization of 603.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-16.05%
5-Day Change
-16.05%
1-Month Change
N/A
3-Month Change
-18.27%
6-Month Change
12.78%
Year-to-Date (YTD) Change
-7.49%
1-Year Change
-30.87%
3-Year Change
-15.64%
5-Year Change
-47.82%
All-Time (Max) Change
227.35%

Contact Information

https://www.xvivoperfusion.com
46 3 17 88 21 50
MAessans gata 10, Gothenburg, NaN, 412 51

Company Facts

193 Employees
IPO DateJul 21, 2014
CountrySE
Actively Trading

Frequently Asked Questions